{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:09:42Z","timestamp":1790633382078,"version":"4.1.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Bisphenol A (BPA), nonylphenol (NP), and octylphenol (OP) are common environmental phenolic endocrine disruptors and widely used industrial chemicals that have garnered significant attention due to their potential to disrupt endocrine functions. These compounds are known to interfere with hormonal activities, particularly those related to estrogen, and are linked to the onset and progression of breast cancer. This study aims to systematically investigate the potential relationship between BPA, NP, and OP and breast cancer risk, along with their underlying molecular mechanisms, by synthesizing data from multiple databases. We initially acquired the chemical structures and SMILES representations of BPA, NP, and OP from the PubChem database. Subsequently, we utilized multiple databases, including the Comparative Toxicogenomics Database (CTD), SEA, and Swiss Target Prediction, t0 estimate their probable biological targets. The predicted targets were standardized and consolidated to form a comprehensive target database. Breast cancer-related targets were subsequently identified from the GeneCards and DisGeNET databases, and their overlap with the targets of BPA, NP, and OP was analyzed to pinpoint potential breast cancer risk targets. To elucidate the functional pathways involved, we conducted Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses using the DAVID database. This analysis offered insights into the molecular pathways influenced by BPA, NP, and OP in the context of breast cancer. Additionally, we utilized machine learning algorithms, specifically Least Absolute Shrinkage and Selection Operator (LASSO) regression and Support Vector Machine (SVM), to identify nuclear targets linked to BPA, NP, and OP-induced breast cancer. These nuclear targets were further validated through differential expression analysis and Receiver Operating Characteristic (ROC) curve analysis using the GEO dataset GSE42568. We also performed a Single Gene Gene Set Enrichment Analysis (GSEA) to investigate the potential regulatory mechanisms of these nuclear genes in breast cancer. The infiltration of immune cells in breast cancer tissues was analyzed using single-sample gene set enrichment analysis (ssGSEA), and the correlation between nuclear targets and immune cell infiltration was examined. Finally, molecular docking and molecular dynamics simulations were conducted to assess the binding affinity and stability of BPA, NP, and OP with their nuclear targets. In this study, we integrated network toxicology, machine learning and multi-omics validation, and identified for the first time that BPA, NP and OP may induce breast cancer through 156 common targets; among them, MAOA, MGLL, ADRA2A, RPN2, GF1R and CTSD were identified as the key causative genes, with a diagnostic efficacy of 0.80\u20130.94 AUC. Mechanistically, these genes are concentrated in the GPCR\/MAPK\/JNK, sphingolipid, and prolactin signaling pathways, which regulate the Wnt\/TGF-\u03b2\/chemokine network and dramatically modify the immunological infiltration of nine classes of M0-M2 macrophages and CD4\u207a T cells. Molecular docking and kinetic simulations suggested the strong affinity of BPA for MGLL, and the complex was stabilized with \u2265\u20093 hydrogen bonds. In conclusion, phenolic endocrine disruptors may cause breast cancer through the \u201cmulti-target-immune microenvironment-metabolic reprogramming\u201d axis, and MAOA, MGLL, ADRA2A, and RPN2 may serve as new targets for early detection and management.<\/jats:p>","DOI":"10.1038\/s41598-026-39706-x","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T06:45:59Z","timestamp":1770792359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The contribution of phenolic endocrine-disrupting chemicals to breast cancer risk: A comprehensive bioinformatics analysis"],"prefix":"10.1038","volume":"16","author":[{"given":"Yanhong","family":"Dou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongxiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"39706_CR1","doi-asserted-by":"publisher","first-page":"140366","DOI":"10.1016\/j.scitotenv.2020.140366","volume":"742","author":"K Wang","year":"2020","unstructured":"Wang, K., Larkin, T., Singhal, N. & Zhao, Y. Leachability of endocrine disrupting chemicals (EDCs) in municipal sewage sludge: effects of EDCs interaction with dissolved organic matter. Sci. Total Environ. 742, 140366. https:\/\/doi.org\/10.1016\/j.scitotenv.2020.140366 (2020).","journal-title":"Sci. Total Environ."},{"key":"39706_CR2","doi-asserted-by":"publisher","first-page":"120645","DOI":"10.1016\/j.watres.2023.120645","volume":"245","author":"Y Xiao","year":"2023","unstructured":"Xiao, Y., Han, D., Currell, M., Song, X. & Zhang, Y. Review of endocrine disrupting compounds (EDCs) in china\u2019s water environments: implications for environmental fate, transport and health risks. Water Res. 245, 120645. https:\/\/doi.org\/10.1016\/j.watres.2023.120645 (2023).","journal-title":"Water Res."},{"key":"39706_CR3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1080\/10473289.2001.10464292","volume":"51","author":"RA Rudel","year":"2001","unstructured":"Rudel, R. A. et al. Identification of selected hormonally active agents and animal mammary carcinogens in commercial and residential air and dust samples. J. Air Waste Manag Assoc. 51, 499\u2013513. https:\/\/doi.org\/10.1080\/10473289.2001.10464292 (2001).","journal-title":"J. Air Waste Manag Assoc."},{"key":"39706_CR4","doi-asserted-by":"publisher","unstructured":"Goralczyk, K. A review of the impact of selected anthropogenic chemicals from the group of endocrine disruptors on human health. Toxics 9 https:\/\/doi.org\/10.3390\/toxics9070146 (2021).","DOI":"10.3390\/toxics9070146"},{"key":"39706_CR5","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1016\/j.fct.2012.07.059","volume":"50","author":"T Geens","year":"2012","unstructured":"Geens, T. et al. A review of dietary and non-dietary exposure to bisphenol-A. Food Chem. Toxicol. 50, 3725\u20133740. https:\/\/doi.org\/10.1016\/j.fct.2012.07.059 (2012).","journal-title":"Food Chem. Toxicol."},{"key":"39706_CR6","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/bph.13622","volume":"174","author":"I Rietjens","year":"2017","unstructured":"Rietjens, I., Louisse, J. & Beekmann, K. The potential health effects of dietary phytoestrogens. Br. J. Pharmacol. 174, 1263\u20131280. https:\/\/doi.org\/10.1111\/bph.13622 (2017).","journal-title":"Br. J. Pharmacol."},{"key":"39706_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.etap.2015.06.009","volume":"40","author":"ER Kabir","year":"2015","unstructured":"Kabir, E. R., Rahman, M. S. & Rahman, I. A review on endocrine disruptors and their possible impacts on human health. Environ. Toxicol. Pharmacol. 40, 241\u2013258. https:\/\/doi.org\/10.1016\/j.etap.2015.06.009 (2015).","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"39706_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.mce.2017.02.045","volume":"457","author":"M Di Donato","year":"2017","unstructured":"Di Donato, M. et al. Recent advances on bisphenol-A and endocrine disruptor effects on human prostate cancer. Mol. Cell. Endocrinol. 457, 35\u201342. https:\/\/doi.org\/10.1016\/j.mce.2017.02.045 (2017).","journal-title":"Mol. Cell. Endocrinol."},{"key":"39706_CR9","doi-asserted-by":"publisher","unstructured":"Nettore, I. C., Colao, A. & Macchia, P. E. Nutritional and environmental factors in thyroid carcinogenesis. Int. J. Environ. Res. Public. Health. 15 https:\/\/doi.org\/10.3390\/ijerph15081735 (2018).","DOI":"10.3390\/ijerph15081735"},{"key":"39706_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.mce.2016.10.003","volume":"457","author":"M Morgan","year":"2017","unstructured":"Morgan, M., Deoraj, A., Felty, Q. & Roy, D. Environmental estrogen-like endocrine disrupting chemicals and breast cancer. Mol. Cell. Endocrinol. 457, 89\u2013102. https:\/\/doi.org\/10.1016\/j.mce.2016.10.003 (2017).","journal-title":"Mol. Cell. Endocrinol."},{"key":"39706_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3967\/0895-3988.2011.01.005","volume":"24","author":"X Jing","year":"2011","unstructured":"Jing, X., Bing, S., Xiaoyan, W., Xiaojie, S. & Yongning, W. A study on bisphenol A, nonylphenol, and octylphenol in human urine amples detected by SPE-UPLC-MS. Biomed. Environ. Sci. 24, 40\u201346. https:\/\/doi.org\/10.3967\/0895-3988.2011.01.005 (2011).","journal-title":"Biomed. Environ. Sci."},{"key":"39706_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.envint.2015.09.011","volume":"85","author":"SS Andra","year":"2015","unstructured":"Andra, S. S., Charisiadis, P., Arora, M., van Vliet-Ostaptchouk, J. V. & Makris, K. C. Biomonitoring of human exposures to chlorinated derivatives and structural analogs of bisphenol A. Environ. Int. 85, 352\u2013379. https:\/\/doi.org\/10.1016\/j.envint.2015.09.011 (2015).","journal-title":"Environ. Int."},{"key":"39706_CR13","doi-asserted-by":"publisher","first-page":"5438","DOI":"10.1021\/acs.est.5b05387","volume":"50","author":"D Chen","year":"2016","unstructured":"Chen, D. et al. Bisphenol analogues other than BPA: environmental Occurrence, human Exposure, and Toxicity-A review. Environ. Sci. Technol. 50, 5438\u20135453. https:\/\/doi.org\/10.1021\/acs.est.5b05387 (2016).","journal-title":"Environ. Sci. Technol."},{"key":"39706_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.envpol.2017.12.037","volume":"235","author":"W Zhong","year":"2018","unstructured":"Zhong, W., Wang, D. & Wang, Z. Distribution and potential ecological risk of 50 phenolic compounds in three rivers in Tianjin, China. Environ. Pollut. 235, 121\u2013128. https:\/\/doi.org\/10.1016\/j.envpol.2017.12.037 (2018).","journal-title":"Environ. Pollut"},{"key":"39706_CR15","doi-asserted-by":"publisher","first-page":"137946","DOI":"10.1016\/j.scitotenv.2020.137946","volume":"722","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. Source apportionment of phenolic compounds based on a simultaneous monitoring of surface water and emission sources: A case study in a typical region adjacent to Taihu lake watershed. Sci. Total Environ. 722, 137946. https:\/\/doi.org\/10.1016\/j.scitotenv.2020.137946 (2020).","journal-title":"Sci. Total Environ."},{"key":"39706_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"39706_CR17","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s12282-018-00941-4","volume":"26","author":"R Sharma","year":"2019","unstructured":"Sharma, R. Breast cancer incidence, mortality and mortality-to-incidence ratio (MIR) are associated with human development, 1990\u20132016: evidence from global burden of disease study 2016. Breast Cancer. 26, 428\u2013445. https:\/\/doi.org\/10.1007\/s12282-018-00941-4 (2019).","journal-title":"Breast Cancer"},{"key":"39706_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1289\/ehp.95103s7113","volume":"103 Suppl 7","author":"AM Soto","year":"1995","unstructured":"Soto, A. M. et al. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ. Health Perspect. 103 Suppl 7, 113\u2013122. https:\/\/doi.org\/10.1289\/ehp.95103s7113 (1995).","journal-title":"Environ. Health Perspect."},{"key":"39706_CR19","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.ctrv.2014.07.005","volume":"40","author":"A Sonnenblick","year":"2014","unstructured":"Sonnenblick, A., Fumagalli, D., Sotiriou, C. & Piccart, M. Is the differentiation into molecular subtypes of breast cancer important for staging, local and systemic therapy, and follow up? Cancer Treat. Rev. 40, 1089\u20131095. https:\/\/doi.org\/10.1016\/j.ctrv.2014.07.005 (2014).","journal-title":"Cancer Treat. Rev."},{"key":"39706_CR20","doi-asserted-by":"publisher","first-page":"630","DOI":"10.2174\/09298673113209990169","volume":"21","author":"AA Amaro","year":"2014","unstructured":"Amaro, A. A. et al. Endocrine disruptor agent Nonyl phenol exerts an Estrogen-like transcriptional activity on Estrogen receptor positive breast cancer cells. Curr. Med. Chem. 21, 630\u2013640. https:\/\/doi.org\/10.2174\/09298673113209990169 (2014).","journal-title":"Curr. Med. Chem."},{"key":"39706_CR21","doi-asserted-by":"publisher","first-page":"167904","DOI":"10.1016\/j.scitotenv.2023.167904","volume":"905","author":"S Huang","year":"2023","unstructured":"Huang, S. Efficient analysis of toxicity and mechanisms of environmental pollutants with network toxicology and molecular Docking strategy: acetyl tributyl citrate as an example. Sci. Total Environ. 905, 167904. https:\/\/doi.org\/10.1016\/j.scitotenv.2023.167904 (2023).","journal-title":"Sci. Total Environ."},{"key":"39706_CR22","doi-asserted-by":"publisher","first-page":"142711","DOI":"10.1016\/j.chemosphere.2024.142711","volume":"363","author":"J He","year":"2024","unstructured":"He, J., Zhu, X., Xu, K., Li, Y. & Zhou, J. Network toxicological and molecular Docking to investigate the mechanisms of toxicity of agricultural chemical thiabendazole. Chemosphere 363, 142711. https:\/\/doi.org\/10.1016\/j.chemosphere.2024.142711 (2024).","journal-title":"Chemosphere"},{"key":"39706_CR23","doi-asserted-by":"publisher","unstructured":"Pinzi, L. & Rastelli, G. Molecular docking: shifting paradigms in drug discovery. Int. J. Mol. Sci. 20 https:\/\/doi.org\/10.3390\/ijms20184331 (2019).","DOI":"10.3390\/ijms20184331"},{"key":"39706_CR24","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.dld.2024.05.010","volume":"56","author":"I Reyes-Avenda\u00f1o","year":"2024","unstructured":"Reyes-Avenda\u00f1o, I. et al. Identification of key markers for the stages of nonalcoholic fatty liver disease: an integrated bioinformatics analysis and experimental validation. Dig. Liver Dis. 56, 1887\u20131896. https:\/\/doi.org\/10.1016\/j.dld.2024.05.010 (2024).","journal-title":"Dig. Liver Dis."},{"key":"39706_CR25","doi-asserted-by":"publisher","first-page":"1604993","DOI":"10.3389\/fphar.2025.1604993","volume":"16","author":"X Yang","year":"2025","unstructured":"Yang, X. et al. Molecular mechanisms of polychlorinated biphenyls in breast cancer: insights from network toxicology and molecular Docking approaches. Front. Pharmacol. 16, 1604993. https:\/\/doi.org\/10.3389\/fphar.2025.1604993 (2025).","journal-title":"Front. Pharmacol."},{"key":"39706_CR26","doi-asserted-by":"publisher","first-page":"e35409","DOI":"10.1016\/j.heliyon.2024.e35409","volume":"10","author":"Z Zeng","year":"2024","unstructured":"Zeng, Z. et al. Integrating network toxicology and molecular Docking to explore the toxicity of the environmental pollutant Butyl hydroxyanisole: an example of induction of chronic urticaria. Heliyon 10, e35409. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35409 (2024).","journal-title":"Heliyon"},{"key":"39706_CR27","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","volume":"4","author":"G Dennis Jr","year":"2003","unstructured":"Dennis, G. Jr. et al. Database for Annotation, Visualization, and integrated discovery. Genome Biol. 4, P3 (2003).","journal-title":"Genome Biol."},{"key":"39706_CR28","doi-asserted-by":"publisher","first-page":"W169","DOI":"10.1093\/nar\/gkm415","volume":"35","author":"DW Huang","year":"2007","unstructured":"Huang, D. W. et al. DAVID bioinformatics resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 35, W169\u2013175. https:\/\/doi.org\/10.1093\/nar\/gkm415 (2007).","journal-title":"Nucleic Acids Res."},{"key":"39706_CR29","doi-asserted-by":"publisher","first-page":"e0294236","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang, D. et al. SRplot: A free online platform for data visualization and graphing. PLoS One. 18, e0294236. https:\/\/doi.org\/10.1371\/journal.pone.0294236 (2023).","journal-title":"PLoS One"},{"key":"39706_CR30","doi-asserted-by":"publisher","unstructured":"McEligot, A. J., Poynor, V., Sharma, R. & Panangadan, A. Logistic LASSO regression for dietary intakes and breast cancer. Nutrients 12 https:\/\/doi.org\/10.3390\/nu12092652 (2020).","DOI":"10.3390\/nu12092652"},{"key":"39706_CR31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12920-018-0413-3","volume":"11","author":"D Li","year":"2018","unstructured":"Li, D. et al. Genomic analyses based on pulmonary adenocarcinoma in situ reveal early lung cancer signature. BMC Med. Genomics. 11, 106. https:\/\/doi.org\/10.1186\/s12920-018-0413-3 (2018).","journal-title":"BMC Med. Genomics"},{"key":"39706_CR32","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/gutjnl-2019-319292","volume":"69","author":"C Reichling","year":"2020","unstructured":"Reichling, C. et al. Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study. Gut 69, 681\u2013690. https:\/\/doi.org\/10.1136\/gutjnl-2019-319292 (2020).","journal-title":"Gut"},{"key":"39706_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.21873\/cgp.20063","volume":"15","author":"S 33 Huang","year":"2018","unstructured":"33 Huang, S. et al. Applications of support vector machine (SVM) learning in cancer genomics. Cancer Genomics Proteom. 15, 41\u201351. https:\/\/doi.org\/10.21873\/cgp.20063 (2018).","journal-title":"Cancer Genomics Proteom."},{"key":"39706_CR34","doi-asserted-by":"publisher","first-page":"177980","DOI":"10.1016\/j.scitotenv.2024.177980","volume":"958","author":"J Pei","year":"2025","unstructured":"Pei, J. et al. Analyzing the potential targets and mechanisms of chronic kidney disease induced by common synthetic endocrine disrupting compounds (EDCs) in Chinese surface water environment using network toxicology and molecular Docking techniques. Sci. Total Environ. 958, 177980. https:\/\/doi.org\/10.1016\/j.scitotenv.2024.177980 (2025).","journal-title":"Sci. Total Environ."},{"key":"39706_CR35","doi-asserted-by":"publisher","first-page":"125708","DOI":"10.1016\/j.jenvman.2025.125708","volume":"385","author":"C Feng","year":"2025","unstructured":"Feng, C., Yan, W., Mei, Z. & Luo, X. Exploring the toxicological impact of bisphenol a exposure on psoriasis through network toxicology, machine learning, and multi-dimensional bioinformatics analysis. J. Environ. Manage. 385, 125708. https:\/\/doi.org\/10.1016\/j.jenvman.2025.125708 (2025).","journal-title":"J. Environ. Manage."},{"key":"39706_CR36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13020-025-01137-7","volume":"20","author":"XR Wang","year":"2025","unstructured":"Wang, X. R. et al. Unveiling the Immunopharmacological mechanisms of Danggui Yinzi (DGYZ) in treating chronic urticaria: insights from network Pharmacology and experimental validation. Chin. Med. 20, 81. https:\/\/doi.org\/10.1186\/s13020-025-01137-7 (2025).","journal-title":"Chin. Med."},{"key":"39706_CR37","doi-asserted-by":"publisher","unstructured":"Liu, S. et al. Extract of allium Chinense G. Don, a medicinal Plant, ameliorates myocardial Ischemia-Reperfusion injury by inhibiting platelet activation. Curr. Issues Mol. Biol. 47 https:\/\/doi.org\/10.3390\/cimb47070503 (2025).","DOI":"10.3390\/cimb47070503"},{"key":"39706_CR38","doi-asserted-by":"publisher","first-page":"e45860","DOI":"10.1097\/md.0000000000045860","volume":"104","author":"Y Zhong","year":"2025","unstructured":"Zhong, Y., Cai, S., Fang, C. & Dai, W. Exploring the mechanism of Stephania Tetrandra S. Moore in the treatment of cisplatin resistance against ovarian cancer through integration of network Pharmacology and molecular Docking. Med. (Baltim). 104, e45860. https:\/\/doi.org\/10.1097\/md.0000000000045860 (2025).","journal-title":"Med. (Baltim)."},{"key":"39706_CR39","doi-asserted-by":"publisher","unstructured":"Wu, Y. et al. Potassium sorbate triggers kidney injury via dysregulated intercellular communication: A study combining network Toxicology, machine Learning, molecular Docking, and Single-Cell RNA sequencing. iMetaMed n\/a. e70017 https:\/\/doi.org\/10.1002\/imm3.70017 (2025).","DOI":"10.1002\/imm3.70017"},{"key":"39706_CR40","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1039\/d0sc05064d","volume":"12","author":"T Hempel","year":"2021","unstructured":"Hempel, T. et al. Molecular mechanism of inhibiting the SARS-CoV-2 cell entry facilitator TMPRSS2 with camostat and Nafamostat. Chem. Sci. 12, 983\u2013992. https:\/\/doi.org\/10.1039\/d0sc05064d (2021).","journal-title":"Chem. Sci."},{"key":"39706_CR41","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41467-024-55361-0","volume":"16","author":"F Wei","year":"2025","unstructured":"Wei, F., Liu, H., Zhang, W., Wang, J. & Zhang, Y. Drug Inhibition and substrate transport mechanisms of human VMAT2. Nat. Commun. 16, 323. https:\/\/doi.org\/10.1038\/s41467-024-55361-0 (2025).","journal-title":"Nat. Commun."},{"key":"39706_CR42","doi-asserted-by":"publisher","unstructured":"Heller, W. T. Molecular Dynamics Investigation of Lipid-Specific Interactions with a Fusion Peptide. Biomolecules 14, (2024). https:\/\/doi.org\/10.3390\/biom14030285","DOI":"10.3390\/biom14030285"},{"key":"39706_CR43","doi-asserted-by":"publisher","first-page":"118011","DOI":"10.1016\/j.ejmech.2025.118011","volume":"298","author":"B Zhao","year":"2025","unstructured":"Zhao, B. et al. Rational design and identification of potent imidazole-fused autotaxin inhibitors for treatment of idiopathic pulmonary fibrosis. Eur. J. Med. Chem. 298, 118011. https:\/\/doi.org\/10.1016\/j.ejmech.2025.118011 (2025).","journal-title":"Eur. J. Med. Chem."},{"key":"39706_CR44","doi-asserted-by":"publisher","unstructured":"Paquet, E. & Viktor, H. L. Molecular dynamics, Monte Carlo simulations, and Langevin dynamics: a computational review. Biomed. Res. Int. 2015 (183918). https:\/\/doi.org\/10.1155\/2015\/183918 (2015).","DOI":"10.1155\/2015\/183918"},{"key":"39706_CR45","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.envint.2016.09.013","volume":"97","author":"I Katsikantami","year":"2016","unstructured":"Katsikantami, I. et al. A global assessment of phthalates burden and related links to health effects. Environ. Int. 97, 212\u2013236. https:\/\/doi.org\/10.1016\/j.envint.2016.09.013 (2016).","journal-title":"Environ. Int."},{"key":"39706_CR46","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/10937400490512500","volume":"7","author":"SM Choi","year":"2004","unstructured":"Choi, S. M. & Lee, B. M. An alternative mode of action of endocrine-disrupting chemicals and chemoprevention. J. Toxicol. Environ. Health B Crit. Rev. 7, 451\u2013463. https:\/\/doi.org\/10.1080\/10937400490512500 (2004).","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"39706_CR47","doi-asserted-by":"publisher","first-page":"119061","DOI":"10.1016\/j.envpol.2022.119061","volume":"302","author":"A Ismanto","year":"2022","unstructured":"Ismanto, A. et al. Endocrine disrupting chemicals (EDCs) in environmental matrices: Occurrence, fate, health impact, physio-chemical and bioremediation technology. Environ. Pollut. 302, 119061. https:\/\/doi.org\/10.1016\/j.envpol.2022.119061 (2022).","journal-title":"Environ. Pollut"},{"key":"39706_CR48","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s40618-022-01983-4","volume":"46","author":"R Modica","year":"2023","unstructured":"Modica, R., Benevento, E. & Colao, A. Endocrine-disrupting chemicals (EDCs) and cancer: new perspectives on an old relationship. J. Endocrinol. Investig. 46, 667\u2013677. https:\/\/doi.org\/10.1007\/s40618-022-01983-4 (2023).","journal-title":"J. Endocrinol. Investig."},{"key":"39706_CR49","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1289\/ehp.9282","volume":"115","author":"M Durando","year":"2007","unstructured":"Durando, M. et al. Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats. Environ. Health Perspect. 115, 80\u201386. https:\/\/doi.org\/10.1289\/ehp.9282 (2007).","journal-title":"Environ. Health Perspect."},{"key":"39706_CR50","doi-asserted-by":"publisher","first-page":"1429142","DOI":"10.3389\/fendo.2024.1429142","volume":"15","author":"MN Juarez","year":"2024","unstructured":"Juarez, M. N., McDermott, A., Wade, M. G. & Plante, I. Exposure to brominated flame retardants in utero and through lactation delays the development of DMBA-induced mammary cancer: potential effects on subtypes? Front. Endocrinol. (Lausanne). 15, 1429142. https:\/\/doi.org\/10.3389\/fendo.2024.1429142 (2024).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"39706_CR51","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11154-016-9332-9","volume":"16","author":"D Racho\u0144","year":"2015","unstructured":"Racho\u0144, D. Endocrine disrupting chemicals (EDCs) and female cancer: informing the patients. Rev. Endocr. Metab. Disord. 16, 359\u2013364. https:\/\/doi.org\/10.1007\/s11154-016-9332-9 (2015).","journal-title":"Rev. Endocr. Metab. Disord"},{"key":"39706_CR52","doi-asserted-by":"publisher","unstructured":"Al-Ani, M. et al. Bisphenol A (BPA) modifies cancer signaling pathways: A neglected global health threat. J. Xenobiot. 15 https:\/\/doi.org\/10.3390\/jox15060207 (2025).","DOI":"10.3390\/jox15060207"},{"key":"39706_CR53","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jsbmb.2014.02.002","volume":"141","author":"A Bhan","year":"2014","unstructured":"Bhan, A. et al. Bisphenol-A and diethylstilbestrol exposure induces the expression of breast cancer associated long noncoding RNA HOTAIR in vitro and in vivo. J. Steroid Biochem. Mol. Biol. 141, 160\u2013170. https:\/\/doi.org\/10.1016\/j.jsbmb.2014.02.002 (2014).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"39706_CR54","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41574-019-0273-8","volume":"16","author":"MA La Merrill","year":"2020","unstructured":"La Merrill, M. A. et al. Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification. Nat. Rev. Endocrinol. 16, 45\u201357. https:\/\/doi.org\/10.1038\/s41574-019-0273-8 (2020).","journal-title":"Nat. Rev. Endocrinol."},{"key":"39706_CR55","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1021\/acs.est.7b03958","volume":"52","author":"H Jin","year":"2018","unstructured":"Jin, H., Zhu, J., Chen, Z., Hong, Y. & Cai, Z. Occurrence and partitioning of bisphenol analogues in adults\u2019 blood from China. Environ. Sci. Technol. 52, 812\u2013820. https:\/\/doi.org\/10.1021\/acs.est.7b03958 (2018).","journal-title":"Environ. Sci. Technol."},{"key":"39706_CR56","doi-asserted-by":"publisher","first-page":"109960","DOI":"10.1016\/j.envres.2020.109960","volume":"191","author":"M Segovia-Mendoza","year":"2020","unstructured":"Segovia-Mendoza, M. et al. The chemical environmental pollutants BPA and BPS induce alterations of the proteomic profile of different phenotypes of human breast cancer cells: A proposed interactome. Environ. Res. 191, 109960. https:\/\/doi.org\/10.1016\/j.envres.2020.109960 (2020).","journal-title":"Environ. Res."},{"key":"39706_CR57","doi-asserted-by":"publisher","first-page":"e0216469","DOI":"10.1371\/journal.pone.0216469","volume":"14","author":"Q Zhao","year":"2019","unstructured":"Zhao, Q. et al. Bisphenol AF promotes Estrogen receptor-positive breast cancer cell proliferation through amphiregulin-mediated crosstalk with receptor tyrosine kinase signaling. PLoS One. 14, e0216469. https:\/\/doi.org\/10.1371\/journal.pone.0216469 (2019).","journal-title":"PLoS One"},{"key":"39706_CR58","doi-asserted-by":"publisher","first-page":"10573","DOI":"10.1038\/s41598-017-10135-1","volume":"7","author":"MI Palacios-Arreola","year":"2017","unstructured":"Palacios-Arreola, M. I., Nava-Castro, K. E., R\u00edo-Araiza, V. H. D., P\u00e9rez-S\u00e1nchez, N. Y. & Morales-Montor, J. A single neonatal administration of bisphenol A induces higher tumour weight associated to changes in tumour microenvironment in the adulthood. Sci. Rep. 7, 10573. https:\/\/doi.org\/10.1038\/s41598-017-10135-1 (2017).","journal-title":"Sci. Rep."},{"key":"39706_CR59","doi-asserted-by":"publisher","first-page":"109263","DOI":"10.1016\/j.envres.2020.109263","volume":"184","author":"Z Noorimotlagh","year":"2020","unstructured":"Noorimotlagh, Z. et al. Environmental exposure to nonylphenol and cancer progression Risk-A systematic review. Environ. Res. 184, 109263. https:\/\/doi.org\/10.1016\/j.envres.2020.109263 (2020).","journal-title":"Environ. Res."},{"key":"39706_CR60","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.tem.2015.02.003","volume":"26","author":"M Barton","year":"2015","unstructured":"Barton, M. & Prossnitz, E. R. Emerging roles of GPER in diabetes and atherosclerosis. Trends Endocrinol. Metab. 26, 185\u2013192. https:\/\/doi.org\/10.1016\/j.tem.2015.02.003 (2015).","journal-title":"Trends Endocrinol. Metab."},{"key":"39706_CR61","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1080\/15287394.2015.1010464","volume":"78","author":"SJ In","year":"2015","unstructured":"In, S. J., Kim, S. H., Go, R. E., Hwang, K. A. & Choi, K. C. Benzophenone-1 and nonylphenol stimulated MCF-7 breast cancer growth by regulating cell cycle and metastasis-related genes via an Estrogen receptor \u03b1-dependent pathway. J. Toxicol. Environ. Health A. 78, 492\u2013505. https:\/\/doi.org\/10.1080\/15287394.2015.1010464 (2015).","journal-title":"J. Toxicol. Environ. Health A"},{"key":"39706_CR62","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ecoenv.2018.04.023","volume":"158","author":"Z Noorimotlagh","year":"2018","unstructured":"Noorimotlagh, Z., Mirzaee, S. A., Ahmadi, M., Jaafarzadeh, N. & Rahim, F. The possible DNA damage induced by environmental organic compounds: the case of nonylphenol. Ecotoxicol. Environ. Saf. 158, 171\u2013181. https:\/\/doi.org\/10.1016\/j.ecoenv.2018.04.023 (2018).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"39706_CR63","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ygcen.2012.04.005","volume":"178","author":"L Pisapia","year":"2012","unstructured":"Pisapia, L. et al. Effects of some endocrine disruptors on cell cycle progression and murine dendritic cell differentiation. Gen. Comp. Endocrinol. 178, 54\u201363. https:\/\/doi.org\/10.1016\/j.ygcen.2012.04.005 (2012).","journal-title":"Gen. Comp. Endocrinol."},{"key":"39706_CR64","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.tox.2012.10.012","volume":"304","author":"HR Lee","year":"2013","unstructured":"Lee, H. R. & Choi, K. C. 4-tert-Octylphenol stimulates the expression of cathepsins in human breast cancer cells and xenografted breast tumors of a mouse model via an Estrogen receptor-mediated signaling pathway. Toxicology 304, 13\u201320. https:\/\/doi.org\/10.1016\/j.tox.2012.10.012 (2013).","journal-title":"Toxicology"},{"key":"39706_CR65","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41588-022-01041-y","volume":"54","author":"E Danenberg","year":"2022","unstructured":"Danenberg, E. et al. Breast tumor microenvironment structures are associated with genomic features and clinical outcome. Nat. Genet. 54, 660\u2013669. https:\/\/doi.org\/10.1038\/s41588-022-01041-y (2022).","journal-title":"Nat. Genet."},{"key":"39706_CR66","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","volume":"24","author":"MA Harris","year":"2024","unstructured":"Harris, M. A. et al. Towards targeting the breast cancer immune microenvironment. Nat. Rev. Cancer. 24, 554\u2013577. https:\/\/doi.org\/10.1038\/s41568-024-00714-6 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"39706_CR67","doi-asserted-by":"publisher","first-page":"1292046","DOI":"10.3389\/fonc.2023.1292046","volume":"13","author":"L Alvarez-Frutos","year":"2023","unstructured":"Alvarez-Frutos, L. et al. Multiomics insights on the onset, progression, and metastatic evolution of breast cancer. Front. Oncol. 13, 1292046. https:\/\/doi.org\/10.3389\/fonc.2023.1292046 (2023).","journal-title":"Front. Oncol."},{"key":"39706_CR68","doi-asserted-by":"publisher","first-page":"1550003","DOI":"10.3389\/fimmu.2025.1550003","volume":"16","author":"T Xu","year":"2025","unstructured":"Xu, T. et al. Tumor-infiltrating immune cells state-implications for various breast cancer subtypes. Front. Immunol. 16, 1550003. https:\/\/doi.org\/10.3389\/fimmu.2025.1550003 (2025).","journal-title":"Front. Immunol."},{"key":"39706_CR69","doi-asserted-by":"publisher","first-page":"1659011","DOI":"10.3389\/fimmu.2025.1659011","volume":"16","author":"C Chen","year":"2025","unstructured":"Chen, C., Guo, W., Wang, H., Cao, L. & Bai, O. Metabolic-immune axis in the tumor microenvironment: a new strategy for prognostic assessment and precision therapy in DLBCL and FL. Front. Immunol. 16, 1659011. https:\/\/doi.org\/10.3389\/fimmu.2025.1659011 (2025).","journal-title":"Front. Immunol."},{"key":"39706_CR70","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/s42003-025-08867-2","volume":"8","author":"DL Monyak","year":"2025","unstructured":"Monyak, D. L. et al. Mapping the Temporal landscape of breast cancer using epigenetic entropy. Commun. Biol. 8, 1477. https:\/\/doi.org\/10.1038\/s42003-025-08867-2 (2025).","journal-title":"Commun. Biol."},{"key":"39706_CR71","doi-asserted-by":"publisher","first-page":"1002157","DOI":"10.3389\/fgene.2023.1002157","volume":"14","author":"L Qian","year":"2023","unstructured":"Qian, L. et al. Construction of a fatty acid metabolism-related gene signature for predicting prognosis and immune response in breast cancer. Front. Genet. 14, 1002157. https:\/\/doi.org\/10.3389\/fgene.2023.1002157 (2023).","journal-title":"Front. Genet."},{"key":"39706_CR72","doi-asserted-by":"publisher","first-page":"1275461","DOI":"10.3389\/fimmu.2023.1275461","volume":"14","author":"Y Sun","year":"2023","unstructured":"Sun, Y. et al. Metabolic reprogramming involves in transition of activated\/resting CD4(+) memory T cells and prognosis of gastric cancer. Front. Immunol. 14, 1275461. https:\/\/doi.org\/10.3389\/fimmu.2023.1275461 (2023).","journal-title":"Front. Immunol."},{"key":"39706_CR73","doi-asserted-by":"publisher","first-page":"12214","DOI":"10.3390\/cimb46110725","volume":"46","author":"J Cui","year":"2024","unstructured":"Cui, J., Chai, S., Liu, R. & Shen, G. Targeting PGK1: A new frontier in breast cancer therapy under hypoxic conditions. Curr. Issues Mol. Biol. 46, 12214\u201312229. https:\/\/doi.org\/10.3390\/cimb46110725 (2024).","journal-title":"Curr. Issues Mol. Biol."},{"key":"39706_CR74","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1038\/s41467-018-06653-9","volume":"9","author":"CA Egelston","year":"2018","unstructured":"Egelston, C. A. et al. Human breast tumor-infiltrating CD8(+) T cells retain polyfunctionality despite PD-1 expression. Nat. Commun. 9, 4297. https:\/\/doi.org\/10.1038\/s41467-018-06653-9 (2018).","journal-title":"Nat. Commun."},{"key":"39706_CR75","doi-asserted-by":"publisher","unstructured":"Garaud, S. et al. Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer. JCI Insight. 5 https:\/\/doi.org\/10.1172\/jci.insight.129641 (2019).","DOI":"10.1172\/jci.insight.129641"},{"key":"39706_CR76","doi-asserted-by":"publisher","first-page":"189193","DOI":"10.1016\/j.bbcan.2024.189193","volume":"1879","author":"D Feng","year":"2024","unstructured":"Feng, D. et al. CD8(+) T-cell exhaustion: impediment to triple-negative breast cancer (TNBC) immunotherapy. Biochim. Biophys. Acta Rev. Cancer. 1879, 189193. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189193 (2024).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"39706_CR77","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1200\/jco.2011.41.0902","volume":"31","author":"S Loi","year":"2013","unstructured":"Loi, S. et al. Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02\u201398. J. Clin. Oncol. 31, 860\u2013867. https:\/\/doi.org\/10.1200\/jco.2011.41.0902 (2013).","journal-title":"J. Clin. Oncol."},{"key":"39706_CR78","doi-asserted-by":"publisher","first-page":"e1002194","DOI":"10.1371\/journal.pmed.1002194","volume":"13","author":"HR Ali","year":"2016","unstructured":"Ali, H. R., Chlon, L., Pharoah, P. D., Markowetz, F. & Caldas, C. Patterns of immune infiltration in breast cancer and their clinical implications: A Gene-Expression-Based retrospective study. PLoS Med. 13, e1002194. https:\/\/doi.org\/10.1371\/journal.pmed.1002194 (2016).","journal-title":"PLoS Med."},{"key":"39706_CR79","doi-asserted-by":"publisher","first-page":"6175","DOI":"10.1038\/s41467-020-19933-0","volume":"11","author":"YH Park","year":"2020","unstructured":"Park, Y. H. et al. Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome. Nat. Commun. 11, 6175. https:\/\/doi.org\/10.1038\/s41467-020-19933-0 (2020).","journal-title":"Nat. Commun."},{"key":"39706_CR80","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00262-020-02736-z","volume":"70","author":"D Kwapisz","year":"2021","unstructured":"Kwapisz, D. Pembrolizumab and Atezolizumab in triple-negative breast cancer. Cancer Immunol. Immunother. 70, 607\u2013617. https:\/\/doi.org\/10.1007\/s00262-020-02736-z (2021).","journal-title":"Cancer Immunol. Immunother"},{"key":"39706_CR81","doi-asserted-by":"publisher","unstructured":"Munir, M. T. et al. Tumor-Associated macrophages as multifaceted regulators of breast tumor growth. Int. J. Mol. Sci. 22 https:\/\/doi.org\/10.3390\/ijms22126526 (2021).","DOI":"10.3390\/ijms22126526"},{"key":"39706_CR82","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fimmu.2014.00514","volume":"5","author":"P Italiani","year":"2014","unstructured":"Italiani, P. & Boraschi, D. From monocytes to M1\/M2 macrophages: phenotypical vs. Functional differentiation. Front. Immunol. 5, 514. https:\/\/doi.org\/10.3389\/fimmu.2014.00514 (2014).","journal-title":"Front. Immunol."},{"key":"39706_CR83","doi-asserted-by":"publisher","first-page":"113878","DOI":"10.1016\/j.yexcr.2023.113878","volume":"434","author":"S Verma","year":"2024","unstructured":"Verma, S., Ishteyaque, S., Washimkar, K. R., Verma, S. & Nilakanth Mugale, M. Mitochondrial-mediated nuclear remodeling and macrophage polarizations: A key switch from liver fibrosis to HCC progression. Exp. Cell. Res. 434, 113878. https:\/\/doi.org\/10.1016\/j.yexcr.2023.113878 (2024).","journal-title":"Exp. Cell. Res."},{"key":"39706_CR84","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.bbcan.2017.10.007","volume":"1869","author":"M Santoni","year":"2018","unstructured":"Santoni, M. et al. Triple negative breast cancer: key role of Tumor-Associated macrophages in regulating the activity of anti-PD-1\/PD-L1 agents. Biochim. Biophys. Acta Rev. Cancer. 1869, 78\u201384. https:\/\/doi.org\/10.1016\/j.bbcan.2017.10.007 (2018).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"39706_CR85","doi-asserted-by":"publisher","first-page":"13303","DOI":"10.1021\/acsomega.4c11128","volume":"10","author":"E Falbo","year":"2025","unstructured":"Falbo, E., Delre, P. & Lavecchia, A. From Apo to Ligand-Bound: unraveling PPAR\u03b3-LBD conformational shifts via advanced molecular dynamics. ACS Omega. 10, 13303\u201313318. https:\/\/doi.org\/10.1021\/acsomega.4c11128 (2025).","journal-title":"ACS Omega"},{"key":"39706_CR86","doi-asserted-by":"publisher","first-page":"119504","DOI":"10.1016\/j.ecoenv.2025.119504","volume":"309","author":"J Wen","year":"2025","unstructured":"Wen, J. et al. A combined study of network-based prediction and in vitro experimental validation on the procarcinogenic mechanism of Propylparaben in Estrogen receptor-positive breast cancer cells. Ecotoxicol. Environ. Saf. 309, 119504. https:\/\/doi.org\/10.1016\/j.ecoenv.2025.119504 (2025).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"39706_CR87","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1590\/2359-3997000000067","volume":"59","author":"A Bolsoni-Lopes","year":"2015","unstructured":"Bolsoni-Lopes, A. & Alonso-Vale, M. I. Lipolysis and lipases in white adipose tissue - An update. Arch. Endocrinol. Metab. 59, 335\u2013342. https:\/\/doi.org\/10.1590\/2359-3997000000067 (2015).","journal-title":"Arch. Endocrinol. Metab."},{"key":"39706_CR88","doi-asserted-by":"publisher","first-page":"1161960","DOI":"10.3389\/fimmu.2023.1161960","volume":"14","author":"Y Tan","year":"2023","unstructured":"Tan, Y. et al. Monoacylglycerol lipase regulates macrophage polarization and cancer progression in uveal melanoma and pan-cancer. Front. Immunol. 14, 1161960. https:\/\/doi.org\/10.3389\/fimmu.2023.1161960 (2023).","journal-title":"Front. Immunol."},{"key":"39706_CR89","doi-asserted-by":"publisher","first-page":"4915","DOI":"10.7150\/ijbs.86039","volume":"19","author":"Y Liang","year":"2023","unstructured":"Liang, Y. et al. The emerging roles of metabolism in the crosstalk between breast cancer cells and tumor-associated macrophages. Int. J. Biol. Sci. 19, 4915\u20134930. https:\/\/doi.org\/10.7150\/ijbs.86039 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"39706_CR90","doi-asserted-by":"publisher","first-page":"122509","DOI":"10.1016\/j.ijpharm.2022.122509","volume":"631","author":"C Jin","year":"2023","unstructured":"Jin, C. et al. Doxorubicin-isoniazid conjugate regulates immune response and tumor microenvironment to enhance cancer therapy. Int. J. Pharm. 631, 122509. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122509 (2023).","journal-title":"Int. J. Pharm."},{"key":"39706_CR91","doi-asserted-by":"publisher","first-page":"846562","DOI":"10.3389\/fphar.2022.846562","volume":"13","author":"H Chen","year":"2022","unstructured":"Chen, H. et al. Transcriptome changes and potential immunotoxicity analysis in RAW264.7 macrophages caused by bisphenol F. Front. Pharmacol. 13, 846562. https:\/\/doi.org\/10.3389\/fphar.2022.846562 (2022).","journal-title":"Front. Pharmacol."},{"key":"39706_CR92","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1038\/s41467-021-23164-2","volume":"12","author":"YC Wang","year":"2021","unstructured":"Wang, Y. C. et al. Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy. Nat. Commun. 12, 3530. https:\/\/doi.org\/10.1038\/s41467-021-23164-2 (2021).","journal-title":"Nat. Commun."},{"key":"39706_CR93","doi-asserted-by":"publisher","unstructured":"Wang, X. et al. Targeting monoamine oxidase A for T cell-based cancer immunotherapy. Sci. Immunol. 6 https:\/\/doi.org\/10.1126\/sciimmunol.abh2383 (2021).","DOI":"10.1126\/sciimmunol.abh2383"},{"key":"39706_CR94","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1158\/2326-6066.Cir-16-0060","volume":"4","author":"B Homet Moreno","year":"2016","unstructured":"Homet Moreno, B. et al. Response to programmed cell Death-1 Blockade in a murine melanoma syngeneic model requires Costimulation, CD4, and CD8 T cells. Cancer Immunol. Res. 4, 845\u2013857. https:\/\/doi.org\/10.1158\/2326-6066.Cir-16-0060 (2016).","journal-title":"Cancer Immunol. Res."},{"key":"39706_CR95","doi-asserted-by":"publisher","unstructured":"Sun, W. Y., Choi, J., Cha, Y. J. & Koo, J. S. Evaluation of the expression of amine oxidase proteins in breast cancer. Int. J. Mol. Sci. 18 https:\/\/doi.org\/10.3390\/ijms18122775 (2017).","DOI":"10.3390\/ijms18122775"},{"key":"39706_CR96","doi-asserted-by":"publisher","first-page":"105004","DOI":"10.1016\/j.critrevonc.2025.105004","volume":"217","author":"MC Hsu","year":"2025","unstructured":"Hsu, M. C., Chen, Y. F. & Yamaguchi, H. KMT2C mutations in breast cancer: molecular mechanisms of cancer promotion, clinical significance, and potential as biomarkers. Crit. Rev. Oncol. Hematol. 217, 105004. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.105004 (2025).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"39706_CR97","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1111\/bcp.14030","volume":"85","author":"EM Rivero","year":"2019","unstructured":"Rivero, E. M. et al. Prognostic significance of \u03b1- and \u03b22-adrenoceptor gene expression in breast cancer patients. Br. J. Clin. Pharmacol. 85, 2143\u20132154. https:\/\/doi.org\/10.1111\/bcp.14030 (2019).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"39706_CR98","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12253-015-0010-0","volume":"22","author":"B Kaabi","year":"2016","unstructured":"Kaabi, B. et al. ADRA2A germline gene polymorphism is associated to the Severity, but not to the Risk, of breast cancer. Pathol. Oncol. Res. 22, 357\u2013365. https:\/\/doi.org\/10.1007\/s12253-015-0010-0 (2016).","journal-title":"Pathol. Oncol. Res."},{"key":"39706_CR99","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41586-023-06110-8","volume":"618","author":"J Zhu","year":"2023","unstructured":"Zhu, J. et al. Tumour immune rejection triggered by activation of \u03b12-adrenergic receptors. Nature 618, 607\u2013615. https:\/\/doi.org\/10.1038\/s41586-023-06110-8 (2023).","journal-title":"Nature"},{"key":"39706_CR100","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0092-8674(92)90118-v","volume":"69","author":"DJ Kelleher","year":"1992","unstructured":"Kelleher, D. J., Kreibich, G. & Gilmore, R. Oligosaccharyltransferase activity is associated with a protein complex composed of ribophorins I and II and a 48 Kd protein. Cell 69, 55\u201365. https:\/\/doi.org\/10.1016\/0092-8674(92)90118-v (1992).","journal-title":"Cell"},{"key":"39706_CR101","doi-asserted-by":"publisher","first-page":"7318","DOI":"10.1038\/ncomms8318","volume":"6","author":"RU Takahashi","year":"2015","unstructured":"Takahashi, R. U. et al. Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1. Nat. Commun. 6, 7318. https:\/\/doi.org\/10.1038\/ncomms8318 (2015).","journal-title":"Nat. Commun."},{"key":"39706_CR102","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1038\/srep02474","volume":"3","author":"RU 102 Takahashi","year":"2013","unstructured":"102 Takahashi, R. U. et al. Ribophorin II regulates breast tumor initiation and metastasis through the functional suppression of GSK3\u03b2. Sci. Rep. 3, 2474. https:\/\/doi.org\/10.1038\/srep02474 (2013).","journal-title":"Sci. Rep."},{"key":"39706_CR103","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1476-4598-13-134","volume":"13","author":"N Tominaga","year":"2014","unstructured":"Tominaga, N. et al. RPN2-mediated glycosylation of tetraspanin CD63 regulates breast cancer cell malignancy. Mol. Cancer. 13, 134. https:\/\/doi.org\/10.1186\/1476-4598-13-134 (2014).","journal-title":"Mol. Cancer"},{"key":"39706_CR104","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nm.1858","volume":"14","author":"K Honma","year":"2008","unstructured":"Honma, K. et al. RPN2 gene confers docetaxel resistance in breast cancer. Nat. Med. 14, 939\u2013948. https:\/\/doi.org\/10.1038\/nm.1858 (2008).","journal-title":"Nat. Med."},{"key":"39706_CR105","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1158\/1078-0432.Ccr-25-0553","volume":"31","author":"EF Petricoin","year":"2025","unstructured":"Petricoin, E. F. et al. Immune and growth factor signaling pathways are associated with pathologic complete response to an Anti-Type I Insulin-like growth factor receptor regimen in patients with breast cancer. Clin. Cancer Res. 31, 4361\u20134371. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-25-0553 (2025).","journal-title":"Clin. Cancer Res."},{"key":"39706_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/cmar.S316700","volume":"14","author":"Y Fan","year":"2022","unstructured":"Fan, Y. & He, S. The characteristics of tumor microenvironment in triple negative breast cancer. Cancer Manag Res. 14, 1\u201317. https:\/\/doi.org\/10.2147\/cmar.S316700 (2022).","journal-title":"Cancer Manag Res."},{"key":"39706_CR107","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13058-018-1063-2","volume":"20","author":"AE Obr","year":"2018","unstructured":"Obr, A. E. et al. Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from Endoplasmic reticulum stress and regulates the tumor microenvironment. Breast Cancer Res. 20, 138. https:\/\/doi.org\/10.1186\/s13058-018-1063-2 (2018).","journal-title":"Breast Cancer Res."},{"key":"39706_CR108","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s12276-024-01163-9","volume":"56","author":"SG Lee","year":"2024","unstructured":"Lee, S. G. et al. Cathepsin D promotes polarization of tumor-associated macrophages and metastasis through TGFBI-CCL20 signaling. Exp. Mol. Med. 56, 383\u2013394. https:\/\/doi.org\/10.1038\/s12276-024-01163-9 (2024).","journal-title":"Exp. Mol. Med."},{"key":"39706_CR109","doi-asserted-by":"publisher","first-page":"6173","DOI":"10.7150\/thno.58254","volume":"11","author":"LB Alcaraz","year":"2021","unstructured":"Alcaraz, L. B. et al. A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment. Theranostics 11, 6173\u20136192. https:\/\/doi.org\/10.7150\/thno.58254 (2021).","journal-title":"Theranostics"},{"key":"39706_CR110","doi-asserted-by":"publisher","first-page":"5133","DOI":"10.1038\/s41467-020-18935-2","volume":"11","author":"S Ketterer","year":"2020","unstructured":"Ketterer, S. et al. Cathepsin D deficiency in mammary epithelium transiently stalls breast cancer by interference with mTORC1 signaling. Nat. Commun. 11, 5133. https:\/\/doi.org\/10.1038\/s41467-020-18935-2 (2020).","journal-title":"Nat. Commun."},{"key":"39706_CR111","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/s41586-023-06498-3","volume":"621","author":"XQ Wang","year":"2023","unstructured":"Wang, X. Q. et al. Spatial predictors of immunotherapy response in triple-negative breast cancer. Nature 621, 868\u2013876. https:\/\/doi.org\/10.1038\/s41586-023-06498-3 (2023).","journal-title":"Nature"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39706-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39706-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39706-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:04:06Z","timestamp":1781633046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39706-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":111,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["39706"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-39706-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"22 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent for publication was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"8283"}}